Dr. Hussain presents OS results from the BRCAAway trial in first‑line #mCRPC with DDR defects:
🔹 Abiraterone, olaparib, or the combination in BRCA1/2/ATM
🔹 Median OS longest in Arm 3 (A+O): 46.2 mo
🔹 Arm 3 showed highest 24 & 36‑mo OS 📊
#GU26 #ProstateCancer #Oncology
11 days ago